| Theme | The Present State of Percutaneous Endoscopic Gastrostomy (PEG) | |
|---|---|---|
| Title | PEG for Patients with Cancer | |
| Publish Date | 2013/09 | |
| Author | Norimasa Tsuzuki | Department of Surgery and Palliative Medicine, Fujita Health University School of Medicine |
| Author | Takashi Higashiguchi | Department of Surgery and Palliative Medicine, Fujita Health University School of Medicine |
| Author | Akihiro Ito | Department of Surgery and Palliative Medicine, Fujita Health University School of Medicine |
| [ Summary ] | In recent years, there has been an increased focus on cancer treatment for both patients and their families. There is a demand for high quality medical treatment, particularly for appropriate nutrition management, which is necessary for patients with advanced or recurrent cancer. PEG for patients with cancer is performed for the purpose of nutrition management. It is employed for head and neck cancer, as well as esophageal cancer. It is also used to treat disuse syndrome accompanying long-term cancer treatment. It is utilized for purpose of drainage when there is upper gastric tract obstruction or stenosis, primarily that involving peritonitis carcinomatosa. PEG is performed by making comprehensive decisions on patientsʼ systemic conditions which determine that we may expect a life span of at least one additional month. The patient must be able to withstand the surgical stress of PEG. In particular, PEG for patients with terminal stage cancer is considered to be an invasive operation, and it is important that no complications arise. It is also important for healthcare providers to be aware that PEG has a significant impact on to the patients' and their familiesʼ lives. |
|